Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 787-791, February 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, H.
Right arrow Articles by Kamataki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, H.
Right arrow Articles by Kamataki, T.

Fetus-specific CYP3A7 and Adult-specific CYP3A4 Expressed in Chinese Hamster CHL Cells Have Similar Capacity to Activate Carcinogenic Mycotoxins1

Hisashi Hashimoto, Tetsuya Nakagawa, Tsuyoshi Yokoi, Minoru Sawada2, Susumu Itoh3 and Tetsuya Kamataki4

Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, N12W6, Sapporo, Hokkaido 060, Japan

To assess whether CYP3A4 and CYP3A7 have a similar capacity to activate carcinogenic mycotoxins, we established cell lines stably expressing human CYP3A4 and CYP3A7, which are adult- and fetal-specific forms of cytochrome P450 in human livers, respectively. Each cDNA was introduced into CR-119 cells which had been established by introducing guinea pig NADPH-cytochrome P450 reductase cDNA into Chinese hamster lung cells. The cell lines (4-line and 7-line) stably expressed the mRNA and the protein corresponding to CYP3A4 and CYP3A7, respectively. The concentration-response for aflatoxin B1 (AFB1) cytotoxicity in 4-line and 7-line, respectively, was compared. 4–10 and 7–40 cells were approximately 17- and 20 times more sensitive to AFB1 than the parental CR-119 cells, respectively. In addition, the sensitivities to AFB1 of both 4–10 and 7–40 cells were enhanced approximately seven times by the addition of 10 µM {alpha}-naphthoflavone, a known activator of CYP3A enzyme, while the sensitivities were suppressed approximately four times by the addition of 100 µM troleandomycin, which forms a metabolite intermediate complex with CYP3A enzyme. Moreover, both cell lines showed approximately 10 and 2 times higher sensitivity to sterigmatocystin and aflatoxin G1 than CR-119 cells, respectively. These results indicate that CYP3A4 and CYP3A7 have essentially similar capacities to activate AFB1, sterigmatocystin, and aflatoxin G1 to produce toxic metabolites.

1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture of Japan.

2 Present address: Division of Environmental Hygiene, Hokkaido Institute of Pharmaceutical Sciences, 7-1 Katsuraoka-cho, Otaru, Hokkaido 047-02, Japan.

3 Present address: Division of Bio-Medical and Immunology, Faculty of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565, Japan.

4 To whom requests for reprints should be addressed.

Received 10/ 4/94. Accepted 12/ 8/94.




This article has been cited by other articles:


Home page
PediatricsHome page
G. Ginsberg, D. Hattis, R. Miller, and B. Sonawane
Pediatric Pharmacokinetic Data: Implications for Environmental Risk Assessment for Children
Pediatrics, April 1, 2004; 113(4/S1): 973 - 983.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
N. Ariyoshi, S. Imaoka, K. Nakayama, Y. Takahashi, K.-I. Fujita, Y. Funae, and T. Kamataki
Comparison of the Levels of Enzymes Involved in Drug Metabolism between Transgenic or Gene-knockout and the Parental Mice
Toxicol Pathol, January 1, 2001; 29(1_suppl): 161 - 172.
[Abstract] [PDF]


Home page
Cancer Res.Home page
N. Kondoh, T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi, N. Goseki, O. Matsubara, K. Takenaka, M. Shichita, et al.
Identification and Characterization of Genes Associated with Human Hepatocellular Carcinogenesis
Cancer Res., October 1, 1999; 59(19): 4990 - 4996.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Bylund, T. Kunz, K. Valmsen, and E. H. Oliw
Cytochromes P450 with Bisallylic Hydroxylation Activity on Arachidonic and Linoleic Acids Studied with Human Recombinant Enzymes and with Human and Rat Liver Microsomes
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 51 - 60.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Saito, Y. Takahashi, H. Hashimoto, and T. Kamataki
Novel Transcriptional Regulation of the Human CYP3A7 Gene by Sp1 and Sp3 through Nuclear Factor kappa B-like Element
J. Biol. Chem., October 5, 2001; 276(41): 38010 - 38022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.